Ahmed Awad
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Year:
2025
Year:
2025
Year:
2024
In light of the COVID-19 global pandemic caused by SARS-CoV-2, ongoing research has centered on minimizing viral spread either by stopping viral entry or inhibiting viral replication. Repurposing antiviral drugs, typically nucleoside analogs, has proven successful at inhibiting virus replication. This review summarizes current information regarding coronavirus classification and characterization and presents the broad clinical consequences of SARS-CoV-2 activation of the angiotensin-converting enzyme 2 (ACE2) receptor expressed in different human cell types. It provides publicly available knowledge on the chemical nature of proposed therapeutics and their target biomolecules to assist in the identification of potentially new drugs for the treatment of SARS-CoV-2 infection.
Year:
2023
Collaborators (3)
Kareem Awad
University of Turku
Donato Gemmati
Full Professor (Molecular Medicine & Genomics)
University of Ferrara
Ilkka Julkunen
Professor of Virology
University of Turku
Make your next move.
Prepare your application
Review drafts before you send them.